DoubleVerify (NYSE:DV) Announces Quarterly Earnings Results

DoubleVerify (NYSE:DV) issued its quarterly earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01, Briefing.com reports. The business had revenue of $140.70 million for the quarter, compared to the consensus estimate of $138.25 million. DoubleVerify had a return on equity of 7.29% and a net margin of 12.48%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period in the prior year, the firm posted $0.07 earnings per share.

DoubleVerify Trading Down 40.0 %

DV traded down $12.24 during trading on Wednesday, hitting $18.33. The company’s stock had a trading volume of 13,470,889 shares, compared to its average volume of 1,956,029. The firm has a market capitalization of $3.15 billion, a price-to-earnings ratio of 44.61, a P/E/G ratio of 3.24 and a beta of 1.11. The business’s fifty day simple moving average is $32.06 and its 200 day simple moving average is $34.35. DoubleVerify has a twelve month low of $17.74 and a twelve month high of $43.00.

Wall Street Analysts Forecast Growth

DV has been the subject of several recent analyst reports. JPMorgan Chase & Co. lowered their price target on DoubleVerify from $32.00 to $30.00 and set a “neutral” rating for the company in a report on Thursday, February 29th. Macquarie raised shares of DoubleVerify from a “neutral” rating to an “outperform” rating and set a $40.00 target price on the stock in a research report on Monday, March 11th. TheStreet raised shares of DoubleVerify from a “d+” rating to a “c-” rating in a report on Thursday, February 29th. Wells Fargo & Company dropped their price objective on shares of DoubleVerify from $44.00 to $41.00 and set an “overweight” rating on the stock in a report on Friday, March 1st. Finally, Bank of America reduced their target price on DoubleVerify from $47.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, February 29th. Two analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $38.79.

Insider Transactions at DoubleVerify

In other news, insider Julie Eddleman sold 900 shares of DoubleVerify stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $30.30, for a total value of $27,270.00. Following the sale, the insider now owns 137,668 shares in the company, valued at $4,171,340.40. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, insider Julie Eddleman sold 900 shares of the business’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $30.30, for a total transaction of $27,270.00. Following the transaction, the insider now directly owns 137,668 shares in the company, valued at $4,171,340.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Nicola T. Allais sold 5,292 shares of DoubleVerify stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $33.45, for a total value of $177,017.40. Following the transaction, the chief financial officer now owns 73,030 shares in the company, valued at approximately $2,442,853.50. The disclosure for this sale can be found here. Insiders sold a total of 91,531 shares of company stock valued at $3,043,004 in the last three months. 3.00% of the stock is currently owned by company insiders.

About DoubleVerify

DoubleVerify Holdings, Inc provides a software platform for digital media measurement, and data analytics in the United States and internationally. The company provides solutions to advertisers that enable advertisers to increase the effectiveness and quality and return on their digital advertising investments.